Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Tables)

v3.23.2
Other current assets (Tables)
6 Months Ended
Jun. 30, 2023
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

June 30, 

December 31, 

    

2023

    

2022

Research and development credits receivable

 

$

37,863

$

30,162

Prepayments

 

13,040

9,472

Clinical materials

 

1,334

1,279

VAT receivable

92

490

Other current assets

 

1,765

1,927

$

54,094

$

43,330